Teodoro Bottiglieri, PhD | Psychiatrist.com

Review Article

Adenosylmethionine (SAMe) for Depression

June 28, 2017

Read a systematic review on S-adenosylmethionine (SAMe) for treatment of neuropsychiatric conditions, depression, and comorbid medical conditions.

Anup Sharma, Patricia Gerbarg, Teodoro Bottiglieri, et al

Letter to the Editor

Failed Studies Should Not Be Used to Malign Good Treatments

November 24, 2014

Patricia L. Gerbarg, Philip R. Muskin, Teodoro Bottiglieri, et al

Original Research

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

April 15, 2014

George I. Papakostas, Richard C. Shelton, John M. Zajecka, et al

Original Research

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

May 15, 2012

David Mischoulon, Jonathan E. Alpert, Erland Arning, et al

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

August 16, 2004

George I. Papakostas, Timothy Petersen, David Mischoulon, et al

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

August 16, 2004

George I. Papakostas, Timothy Petersen, David Mischoulon, et al